← Eichor
Condition: Locally Advanced Prostate Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Locally Advanced Prostate Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · Angela Y. Jia, MD PhD · NCT06574880Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recu
Phase 2 · 1 location(s) · Mayo Clinic · NCT07073794Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
Phase 2 · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06387056A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastati
Phase 1/Phase 2 · 1 location(s) · CuraCell TX AB · NCT07255664Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1 · 2 location(s) · Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd · NCT06666270Imaging of Solid Tumors Using 18F-TRX
Phase 1 · 1 location(s) · Rahul Aggarwal · NCT06942104Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in
Phase N/A · 1 location(s) · Oncology Institute of Southern Switzerland · NCT04543799Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Phase 1 · 10 location(s) · Nammi Therapeutics Inc · NCT06582017Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advance
NA · 1 location(s) · N.N. Alexandrov National Cancer Centre · NCT07308990Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Phase 1 · 20 location(s) · SystImmune Inc. · NCT07080242Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Phase 1 · 1 location(s) · University of Oklahoma · NCT06130995Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer
NA · 30 location(s) · Olof Akre · NCT02102477Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
Phase 2 · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT05406999Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastat
NA · 1 location(s) · Medical University of Vienna · NCT02971358Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 · 18 location(s) · MOMA Therapeutics · NCT06545942First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine
Phase 1 · 4 location(s) · Oxford Vacmedix UK Ltd. · NCT05104515FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 33 location(s) · Parabilis Medicines, Inc. · NCT05919264177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Phase 1/Phase 2 · 4 location(s) · Radiopharm Theranostics, Ltd · NCT07189871Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410494Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT07325721Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04947254A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate
Phase 3 · 342 location(s) · AstraZeneca · NCT06952803Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions
NA · 3 location(s) · Rigshospitalet, Denmark · NCT07343349Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
NA · 2 location(s) · University of Southern California · NCT06500169A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants Wi
Phase 1 · 11 location(s) · IDEAYA Biosciences · NCT07540572A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 · 85 location(s) · Daiichi Sankyo · NCT06172478A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Phase 1 · 6 location(s) · Angiex, Inc. · NCT06440005Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer
NA · 2 location(s) · National Taiwan University Hospital · NCT04894188A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Phase 1 · 10 location(s) · Dren Bio · NCT06999187EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410676
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.